Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Commiphora mukul vs mefenamic acid in abnormal menstrual bleeding
IRCT20211125053177N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of commiphora mukul and Mefenamic acid in hypermenorrhea (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoint: Change in abnormal menstrual bleeding. Started Jul 2022; status: completed.
02
Drugs
commiphora mukulMefenamic acid
03
Conditions
hypermenorrhea
Beyond the preview
Go deeper on IRCT20211125053177N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211125053177N1.